Cargando…
Caplacizumab for treating subacute intra-stent thrombus occurring despite efficacious double anti-platelet treatment and anticoagulation: a case report
BACKGROUND: Acute and subacute stent thromboses are a rare complication associated with high mortality and morbidity occurring in ∼1.5% of patients treated with primary percutaneous intervention for ST-elevation myocardial infarction (STEMI). Recent publications describe a potential role of the von...
Autores principales: | Stalder, Gregoire, Chatte, Antoine, De Rossi, Noemy, Yerly, Patrick, Alberio, Lorenzo, Eeckhout, Eric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9924497/ https://www.ncbi.nlm.nih.gov/pubmed/36793934 http://dx.doi.org/10.1093/ehjcr/ytac497 |
Ejemplares similares
-
Pseudoreticulocytosis in a patient with myelodysplastic syndrome
por: De Rossi, Noemy, et al.
Publicado: (2021) -
Caplacizumab: First Global Approval
por: Duggan, Sean
Publicado: (2018) -
Caplacizumab for thrombotic thrombocytopenic purpura
Publicado: (2020) -
Subacute Stent Thrombosis in a Patient With COVID-19 Despite Adherence to Antiplatelets
por: Elkholy, Karim O, et al.
Publicado: (2021) -
Correction to: Caplacizumab: First Global Approval
por: Duggan, Sean
Publicado: (2018)